Pharmacist’s Role in Managing and Preventing Newborn and Infants Sepsis: A Prospective Observational Review

Abstract

Background: Worldwide, neonatal and infant sepsis continues to be a major cause of morbidity and mortality, contributing to 15% of all neonatal fatalities. Using efficient management techniques is essential to enhancing results and lowering antibiotic resistance. Additionally, the absence of diseases, infection cases may occasionally have negative consequences. For this reason, the physician cannot make a decision. Many factors, such as the baby's clinical health, hospital hygiene, and other factors, are to blame for this. It is necessary to find a quick and accurate diagnostic process to prevent inconsistent results. Approximately 30 to 50% of baby deaths in developing nations are caused by sepsis. Early detection, rigorous treatment, and anti-microbial medications can all help reduce and prevent this sepsis fatality rate. Each time we interact with a baby, we must wash our hands to avoid nosocomial infections.Pharmacist-led initiatives have demonstrated potential for improving patient care and optimizing antimicrobial therapy. Objective: To investigate the impact of pharmacist-led interventions on neonatal and infant sepsis management, focusing on incidence density, pathogen identification, antibiotic misuse, hospital stay, and mortality rates.

Keywords

Group B streptococci (GBS), Premature rupture of membrane (PROM), Early onset of sepsis (EOS), Late onset of sepsis (LOS), Total leukocyte count (TLC)

Introduction

Newborns are at extremely high risk for neonatal sepsis. Therefore, the evaluation tests associated with neonatal sepsis are quite important. The doctor must quickly diagnose the youngster with sepsis in order to save him. It generally requires longer to confirm sepsis using traditional procedures. Therefore, we must find an effective diagnostic method to verify sepsis.

Infection cases can occasionally have negative effects even in the absence of illnesses. As a result, the doctor cannot decide. Numerous factors, such as the infant's clinical state and hospital hygiene, are to blame for this. Finding a quick and accurate diagnostic process is necessary to prevent inconsistent results.  About 30 to 50 percent of infant deaths in developing nations are caused by sepsis [1,2]. Antimicrobial drugs, intensive care, and early detection can all help reduce and prevent this sepsis fatality rate. After every interaction with the newborn, we must wash our hands to avoid nosocomial infections.

PROPHYLAXIS OF MATERNAL ANTIBIOTICS:

1. The hospital's approach to Group B Streptococci (GBS) is critical-based.

2. It is important to identify risk factors throughout pregnancy.

3. GBS has not been totally eradicated, despite the fact that it can be identified and treated during pregnancy.

4. Administer intravenous antibiotics for a minimum of four hours to guarantee sufficient coverage.

5. Eighty percent of newborn infections occur within seven days of birth.

6. It is a devastating factor if untreated. Newborn babies may die because of this.

GBS Critical factors

1. A previously GBS neonatal birth was acquired.

2. The colonization of GBS throughout the present pregnancy.

3. The duration of an elongated membrane rupture (ROM) exceeds 18 hours.

4. Postpartum maternal fever.

No antibiotics indications:

The cesarean section performed on a healthy mother with intact membranes and a risk of GBS before labor begins.

Previous new baby with GBS

A previously GBS newborn or bacterial colonies with GBS.  PROMs at term prior to the start of labor and the timely administration of gentamicin and amoxicillin in the event of a microbial infection during pregnancy.  In the term before to the onset of labor-induced labor (at the time of induction), PROMs are administered penicillin.

Neonatal sepsis

Any signs or symptoms that suggest chorioamnionitis or maternal sepsis, including high WCC or CRP, undesirable vaginal discharge, a temperature exceeding 38 degrees, tachycardia in the mother or fetus, rigors, a sensitive uterus, and fast gentamicin treatment.

PROM and NIL Factors of Risk

Penicillin should be administered for ruptured membranes after 18 hours of labor.

1. When a membrane ruptures and labor occurs, penicillin is given eighteen hours later.

2. During induction, take penicillin if ROM happens outside of labor.

Prophylaxis of Maternal antibiotic:

1. If you are not in labor and PROM <37w, take oral erythromycin for 10 days.

2. Symptoms of sepsis during labor if IV metronidazole, amoxicillin, and gentamicin are administered.

3. Intravenous amoxicillin during in labor.

4. Signs of Sepsis with IV Amoxicillin, Metronidazole, and Gentamicin.

Antibiotic Prophylaxis of Mother- Preterm less than 37 weeks

 1.After taking erythromycin for 10 days, PROM should wait 32 weeks if she is not in labor.

 2. She should get gentamicin and amoxicillin by IV if she is in labor.

 3. Intravenous amoxicillin, gentamicin, and metronidazole in the event of sepsis signs.

4.IV antibiotics (gentamicin and amoxicillin) should be used throughout weeks 32–37 of labor.

5. If sepsis signs are present, administer metronidazole, gentamicin, and amoxicillin intravenously.

Neonatal Blood Stream Infection

Onset sepsis Early Infection

1. EOS may be acquired by hospital-acquired infections or perinatally.

2. Common causes include streptococci, E. coli, GBS, and gram-negative pathogens.

3. The epidemic pattern or sporadic presence of Listeria monocyte genes.

Onset Sepsis Late infection

1. It is brought on by negative Staphylococci in preterm newborns.

2. Gram-negative organisms can also cause late-stage GBS illness in some situations.

Factors of risk

1. PROM

2. Illness of Maternal

3. Presence of pathogens in maternal urine or vaginal swab.

4. Less than 37weeks of prematurity

5. Distress of fetal

6. Gestation of twins.

The risk factors listed above are not just signs of sepsis. Therefore, to prevent sepsis, even minor clinical indications need to be treated as soon as possible. This is due to the rapid transmission of potentially fatal diseases.

Features of Clinical

1. Instable temperature- hypothermia and hyperthermia are often due to issues with environmental temperature, but a body temp. of< 360 or > 37.50 for more than 1 hour is sepsis until proven otherwise.

2. Refusal of feed in previous well child.

3. Inactive Newborn, irritability, pallor child.

4. Rapidly developing jaundice.

5. Paralytic ileus.

6. Apnoea, especially new onset or large occurrence or severity in a premature infant.

Clinical Laboratory Findings

The clinical scenario should also be taken into account apart from blood test to decide the presence of Neonatal sepsis.

FBC

1. WBC total must be <5 and neutropenia less than one.
2. The ratio of immature must be greater than 0.25 on a day.
3. The film contains toxin granulation or Vacuolisation.
4. It must be less than 100 for Thromobo-cytopenia.

CRP

1. For tissue injury, an acute phase reactant synthesized within 6 to 8hours. 2. PROM asphyxia perinatal can be elevated by non-infections process.

3. At the beginning of the illness, the sensitivity lacks to prove sepsis; but after 6hrs, it improves to 90%.

4. The Normal CRP level of<10mg/L.

Microbial Blood Culture

1. Blood of 1ml adequate for the culture of blood.
2. The blood culture result shows no growth because of lack of infection or inadequate sample.

CXR (Chest X-Ray)

1. Respiratory problems in newborn babies must be considered GBS sepsis and treated accordingly.

2. After 4 years of age, no major treatment, hence it must be treated early.

Urinary Tractor Infection Test

1. Urine test must be done, for early-onset sepsis for the antigen of GBS. 2. For UTI no microscopy or culture is required since the value is extremely low.

3. Urine test is if sufficient for PROM. For skin contamination, a catheter sample is enough.

4. If antibiotics have been stopped after 24-48hours and the baby is on the postnatal ward and bag urine collection has been unsuccessful then it can be omitted.

Puncture of Lumber

1. Meningitis are caused by notable blood changes, irrespective of +ve / -ve blood culture.

 2. The investigation may be delayed if the baby is unable to with stand the procedure ie: unstable, ventilated, coagulopathy.

Newborn Antibiotics

1. Amoxycillin (50–100 mg/kg/dose, q12 hours, IV push) is the preferred first antibiotic for suspected or confirmed sepsis given at the time of newborn birth or within 1–48 hours and admitted to NICU. If meningitis or severe sepsis is suspected, use a high dose. Gentamicin (IV infusion based on longer interval dose that is locally developed)

2. Amoxycillin (50 mg/kg/dose, IV push) is required for NICU admission; gentamicin is not now administered intravenously on the postnatal ward because it is an infusion with the necessary levels. However, as there may occasionally be clinical variables that suggest that gentamicin is more appropriate, address each case with the SMO at the proper time.

3. For babies who start their antibiotic course in NICU and are transferred to the ward: Amoxycillin Change Gentamicin to Cefotaxime if a 5-day course is required - this needs to be charted to start at the time that the next gentamicin dose was due

4. The preference is that babies on the postnatal ward have their iv line sited on the postnatal ward.

5. Options to consider are using the Obstetric CCO or Clinical Support Nurse (NICU) when available to help hold and tape. If it is necessary to bring the baby down to NICU for an IV line then call the NICU ACNM to coordinate where this is best to be done given NICU workloads. The intention then would be for the IV line to be placed and the baby returned to the postnatal ward for antibiotic administration.

6. Stop antibiotics 24 to 48 hours after the cultures are negative, the symptoms have subsided, the CRP test is normal, and the white count is normal.

7. Add metronidazole to amoxicillin, gentamicin, vancomycin, or cefotaxime for necrotizing enterocolitis that has been confirmed or suspected.

8. Cotrimoxazole should be used to treat infants with renal tract abnormalities or UTIs. PHARMAC states that certain antibiotics, such as meropenem, piperacillin, and vancomycin, need approval for infectious diseases.

9. This information is found in the drug profile.

10. The antibiotic treatment can begin following the doctor's consultation.

Sepsis of severe type

It can be treated 500mg/kg Immunoglobulin. If the new born baby refuses to antibiotics use Granulocyte-colony stimulating factor (G-CSF).

Newborn Bacterial Sepsis

Clinical syndrome is characterized by infection-related signs and symptoms within the first 30 days of life, regardless of the presence of microorganisms. Pneumonia, meningitis, arthritis, and urinary tract infections are among the various systemic illnesses involved. Conjunctivitis and other superficial infections, such as thrush, are typically excluded from the definition of newborn sepsis. Based on symptoms, neonatal sepsis can be divided into two main types [3]. Early onset sepsis, or EOS, appears 72 hours after delivery. At birth, the newborn could exhibit symptoms. In general, EOS babies experience respiratory difficulties and pneumonia. The source of the infection is the mother's vaginal tract. Increased risk factors for EOS are caused by prenatal conditions. The early identification of sepsis will undoubtedly benefit from awareness of risk factors. The following risk variables are linked to the early onset of EOS, according to Indian studies [4].

NEURODEVELOPMENTAL DISORDERS IN VLBW INFANTS WITH NEONATAL SEPSIS RISK FACTORS

1. Neurodevelopmental disorders in VLBW infants.

2. Mothers febrile illness two weeks before delivery with the infection of bacteria.

3. Smelling of foul.

 4. Membranes rupture

5. Sterilization of vaginal examination during labor is more than 3 numbers.

6. Labour of prolonged time more than 24hrs.

7. Asphyxia of perinatal.

Foul Smelling presence or three risk factors mentioned above require antibiotic treatment and accordingly treated.

LOS (late-onset sepsis) It occurs after 72hours of birth. LOS Sources infections are due to nosocomial, community-acquired and pneumonia. low birth weight, and mechanical ventilation.

  LOS of community-acquired are due to poor hygiene, bottle feeding & feeds of prelacteal, Mother's breastfeeding also helps in the prevention of sepsis [5].

Features of Non-Specific & Clinical

The early signs of sepsis are nonspecific and subtle. For early diagnosis, high suspicion is needed. Sepsis of neonates comes with one or more following symptoms [6].

1. Fever (common in low birth weight)

2. Refusal to Suck, poor cry & lethargy

3. Enlarged refill time of capillary.

4. Neonatal reflexes are nil.

5. Tachycardia.

 6. Distress of respiratory

7. Acidosis of metabolic.

Various Systems Connected to Specific Features

1. CNS: neck retraction, vacuous look, and high-pitched wail.

2. Meningitis cardiae: diarrhea, vomiting, and poor perfusion.

3. Hepatic: Infections of the urinary tract.

4. Acute renal failure.

Rapid results should be made since neonatal sepsis treatment needs to be completed as soon as possible [7]. Blood culture: This routine diagnosis needs to be completed prior to the use of antibiotics. The greatest guide for antimicrobial therapy is a (+)ve blood culture. Therefore, in order to obtain the blood culture, the correct technique must be followed. Provide a crucial process. Prior to the procedure, sterile gloves must be worn by the NICU physician and team. and cover the locations with a skin patch that is 5 cm in diameter. Use 70% alcohol and povidone iodine to clean the area. It is necessary to use this povidone iodine in concentric circles, beginning in the middle. The skin must only be performed in an area with fresh airflow prior to sample collection. Before announcing that blood cultures are sterilized, they must be checked for at least 72 hours. BACTEC and BACT/ALERT 3D are two examples of advanced bacteriological/microbiological techniques that allow us to identify bacterial growth in as little as 12 to 24 hours.

These days, this is achievable. At a concentration of 1-2 colony forming units per milliliter, it can identify bacteria. The septic screen [8,9]. A newborn sepsis screen is required to diagnose suspected neonatal sepsis. Antibiotics cannot be started based only on the results of a sepsis screen. The septic screen needs to include TLC, ANC, and CRP if the clinic had serious concerns about sepsis. The presence or lack of infection can be reliably predicted by haematological markers. Early detection of neonatal sepsis is possible by the detection of haematological markers. Diagnostic tests for neonates must have the highest possible sensitivity and specificity. Highly sensitive and specific inflammatory markers (such as haptoglobins, ELISA, interleukins, and counter immuno electrophoresis, among others) are also employed today, according to a number of researchers. For physicians, treating newborn sepsis early remains a problem. To detect infant sepsis early, a hematologic scoring system (HSS) is used.

The absolute neutrophil count fluctuates significantly during the newborn period, and the Manroes chart [10] provides the ranges of normal reference. For infants with lower birth weights, the ANC normal lower limit at age 12 begins at 1800/cm, increases to 7200/cmm, then falls and stays at 1800/cmm after 72 hours [11]. The IT ratio is less than 0.16 at birth and rises to a high value of 0.12 by 72 hours of age.When two distinct parameters appear in a screen, the sensitivity ranges from 93% to 100%, the specificity is 83%, and the +ve and -ve prediction values for sepsis detection are 27% and 100%, respectively. In the positive screen, neonates must have aberrant values. When doubt persists, even if the screen is(–)ve, the child must be treated within 12hours. Again the result is -ve screen . Sepsis can be ruled out with considerable by considerable surity. LP (lumbar puncture) In neonatal Sepsis, the occurrence of meningitis varies from 0.3to3% according to various studies. There is often an overlap in the hospital features of meningitis & septicemia, Sometimes meningitis also occur without any symptoms. Thus, it demonstrates the need for LP as an additional precaution in newborns suspected of having sepsis. In EOS, LP is recommended if a positive blood culture is present or if the hospital situation is consistent with septicemia. The indication is unavailable if the primary use of antibiotics is for risk factors. In the event of LOS, all newborns should have LP treatment before to beginning antibiotics. LP must be a baby who was post-phoned. It ought to be carried out when the clinical state doesn't change. Cerebrospinal fluid characteristics are unusual throughout the neonatal period [12].

Radiology: Chest X-rays must be considered when respiratory distress is present. The presence of abdominal symptoms indicated by the abdomen x-ray will indicate NEC. For infants with meningitis, a neurosonogram and CT scan must be performed [13].

Culture of urine: Urine culture gives low result &So, they are not taken regularly. In order to avoid UTI (Urinary tract infection). Urine examination must be done. Hence UTI must be performed in the presence of one of the following. a) >10WBC/mm3 in a 10ml in a sample of centrifuged. b) >10 microorganisms/ml for urine got through catheterization. c)The microorganism in urine got by aspiration of suprapubic [14].

Support of Management: A neonate with sepsis has to receive appropriate and sufficient support care. The baby must be cared for in a thermo-nutral environment to prevent hypo. It should be kept within the usual range given the oxygen saturation level. In certain cases, mechanical ventilation may be necessary. hemodynamically unstable. They need to keep an eye on the baby. Using appropriate tropes, adequate blood pressure and normal tissue perfusion are maintained. When anemia or bleeding diathesis is present, utilize packed red blood cells and fresh frozen plasma [15].

Motivation with Problem Statement

Newborn sepsis is the primary issue that frequently arises in developing countries. Shock and failure of many organ systems can result from an infection that triggers the inflammatory cascade that causes neonatal sepsis [16]. It is a clinical syndrome in which a bacterial organism that invades the body affects several systems during the first month of life. Particularly for low-birth-weight babies, it is a major issue in the neonatal intensive care unit [17]. In neonatal sepsis, morbidity and mortality are more prevalent. According to a 2017 UNICEF report, out of 1000 newborns worldwide, about 18 died from neonatal sepsis brought on by a microbe, as well as from other reasons like lack of knowledge and delayed diagnosis. Additionally, it was revealed that in India, neonatal sepsis caused by various bacterial species killed about 30 out of 1000 neonates. Delays in treating neonatal sepsis are the primary cause of newborn seriousness and mortality. According to a recent study, sepsis accounts for one-fourth of neonatal deaths in India, with the majority of cases happening within three days of birth. The Study also found that the infecting pathogens are marked by an alarming degree of antimicrobial resistance [18]. Sepsis frequently affects infants under a year old, adults over 65, and patients with compromised immune systems or long-term illnesses like diabetes. The study found that sepsis is one of the leading causes of newborn fatalities worldwide. Ethiopia, Nigeria, Pakistan, and India are among the countries where newborn infection-related fatalities are prevalent [19].

FACTORS OF NEONATAL DEATHS IN INDIA

Additionally with the increased sepsis rates, the affected infant frequently developed antibiotic resistance. An related commentary states that 56,524 Indian neonates die from bacterial sepsis within a year as a result of their resistance to first-line treatments. In comparison to septicemia produced by microorganisms sensitive to an antimicrobial agent, the rate of sepsis death caused by antibiotic-resistant pathogens was greater. The majority of infants' morbidity and mortality during the first month of life are caused by sepsis, which is a contributing factor to sepsis. Three out of every 1000 live newborns are affected by meningitis. According to Indian estimates, early maturation with the lowest birth mass accounts for 50–60% of septic babies. Neonates with sepsis exhibit nonspecific early clinical symptoms. So that many newborn undergo investigation and starting treatment before the cause for sepsis is decided [20]. The treatment of newborn sepsis is confirmed by culture of blood. The incidence of proven sepsis by blood culture is 2 in 1000 Live Birth. The newborn who is evaluated for septicemia is 7-13% in whom 3 to 8% is culturepositive. The death rate of not treated sepsis can be almost 50%. Newborn septicemia is more prevalent causes of newborn mortality and morbidity, due to the delivery and postnatal care given in an unhealthy environment and low socioeconomic state leading to maternal infection. Pneumonia or meningitis and clinical signs can manifest in early sepsis which is apparent in the first few hours of neonate's life and can have non-specific initial presentations. Even if there is one or two clinical signs and symptoms or if there is any material (or) neonatal risk factors are present even though the neonate may be asymptomatic, in which screening is usually necessary to perform.

Thus early suspicion and diagnosis of neonatal sepsis will help in early treatment with appropriate antibiotics which would reduce the morbidity and mortality in neonates. When the mother had prolonged rupture of the membrane in the birth canal before delivery, which contaminates amniotic fluid causes Septicaemia [21].

Microbiological pathogenic organisms of the mother's vaginal tract are frequently the cause of early-onset infant septic infections. However, NICU/clinic centers or the general public are the source of late-onset septicemia [22]. Newborn sepsis can be brought on by maternal, fetal, and environmental causes.

The ascending infection is considered to be a risk factor for infection in newborn due to PROM as well as infection in the mother, fever during labor, foul smell of amniotic fluid and UTI, Chorioamnionitis Infections. The risk factors contributing to newborn sepsis are low birth weight, birth asphyxia, premature delivery, anomaly and prolonged stay in the newborn ward (NICU) [23].

IF SEPSIS DEVELOPS DURING PREGNANCY, IN THE LABOUR WARD OF A HOSPITAL, A DOCTOR EXAMINES A PREGNANT WOMAN BEFORE HER DELIVERY.

Bacteria can be isolated from blood cultures to diagnose septicemia [24]. In general, it is possible to separate both gram-positive and gram-negative bacteria in the same time period from a particular point to another [25]. The etiological newborn sepsis is commonly gram-negative bacilli in developing countries. The commonly detected organism in the sample included E.coli, Klebsiella pneumonia, Staphylococcus aureus, Streptococcus spp, Citrobactersp and Coagulase Negative Staphyloccus [26]. The organism's susceptibility to different antibiotics varies. The isolation of the drug-resistant bacteria is a growing problem. Beta-lactamase antibiotics are the medication used to treat neonatal sepsis. One of the biggest clinical crises of the past few decades is antibiotic resistance. Resistance to beta-lactamase antimicrobial drugs, particularly cephalosporin, is rising globally as a result of bacterial gram-negative pathogens developing extended-spectrum beta-lactamase (ESBL). Therefore, an appropriate knowledge of the microorganism and the drug's susceptibility patterns is essential for the treatment. In order to determine the cause of neonatal sepsis and its patterns of antibiotic susceptibility, this study was conducted.

The newborn sepsis incidence was correlated with maternal risk factors, for example, PROM and delivery types. When the pathogenic organism enter into the blood, which can produce severe infection without location (Sepsis) or localized to lung as pneumonia or meningitis in meninges. Early onset sepsis (EOS)is called the sepsis occurs within 72hrs of life and that occurs after 3 days is called late-onset sepsis (LOS) infection. EOS infection is due to vertical position transmission of microorganism form mother and LOS is due to horizontal position transmission for health caregivers. The pathogenic microorganism responsible for newborn septicaemia has modified with time and differs from place to place. Newborn septicaemia is the third common cause of newborn mortality after prematurity and birth asphyxia. Sepsis is responsible for for13% of all newborn deaths and during the first week of life, neonatal deaths percentage is 42 only [27].

A large number of newborns in developing countries die at home due to lack of surveillance system before recorded. Sepsis in newborn babies generally reported very low only in developing countries. So that the mortality is very high. Preterm newborn are easily acquire infection than other children cause to innate immunity is less because of impaired cytotoxin production low expression of the adhesion bio molecules in neutrophils and response to chemotactic factors are very low. The antibodies start transplacental during the period of 2nd trimester and reach their maximum or highest during the period of the third trimester. The humoral responses have been reduced significantly in the preterm newborn in which the risk of sepsis is increased due to multiple skin puncture. The WHO introduced 7 clinical signs like feeding difficulty, irritability, lethargy, convulsions, breathing rate is greater than 60 per minute and for severe chest pain, the temperature is greater than37.5ºC (or) less than 35.5ºC which should alert attending Doctors on suspect infection for a referral to tertiary care hospital [28].

The polymerase chain reaction and RT-PCR are two important diagnostic advances by using molecules of the organism to identify the pathogens. Very low birth weight babies generally acquire a fungal infection in a NICU due to factors of risk like presence of central line, skin breakdown, and multiple IV antibiotics. The appropriate antifungal agent like amphotericin is empirically used for a fungal infection until the report is negative. The western world during 1960 the common agent for sepsis was Gram-negative organisms but after 1970, it was changed to group B streptococci. The Staphylococcus aureus emerged as the most common microorganism in the next decades. Bacterial resistance is a common problem across the globe and in this part of India. Resistance to many drugs has increased in the past two decades due to over-the-counter sale, irrational antibiotics usage and the infections controlled poorly at maternity centres. It is important to diagnose the newborn sepsis at an early stage. There are so many diagnostic tests are available includes CRP, ESR, Platelet count and complete blood count, yet the standard method is only blood culture. The continuous reaction of polymerase has been used increasingly to find out the microorganisms in blood samples with high sensitivity and specificity. In Bacterial sepsis, the polymerase chain reaction primers target to protect rDNA gene sequences permit the DNA amplification. The bacteria can be located in the phylogenetic tree after DNA sequencing of the amplification product. As far as the recent information data, the PCR application to diagnose bacteria in the blood is rising. The presence of inhibitory substances in the blood is the common limitation for PCR due to lack of amplification. Relman and Fredricks identified PCR inhibitor and removed it by allowing the DNA bacterial amplification from neonate’s blood cultures without dilute the sample. The PCR has an important impact in the hospital of short duration stays in NICU and also health care cost reduction. The present research study was to find out the newborn bacteraemia by using mostly universal primers are targeted to 16SrRNA followed by sequencing [29]. Inflammation is the body's reaction to an infection in order to  get rid of the infections that are causing it [30]. Pathogens or the byproducts of tissue damage can cause inflammation. Immune cells with certain surface receptors in the circulation can identify either infections or components of dead tissue. In many organ systems, inflammatory cascades are released when immune cells, mostly lymphocytes, attach to surface receptors on mononuclear cells [31]. In addition to the release of inflammatory cascades, inflammatory mediators induce vasodilatation and up-regulation of adhesion molecules. Blood cells primarily neutrophils and monocytes increase in the blood vessels, leukocytes become activated and lymphocytes are released. Cytokines stimulate coagulation; however as bacterial constituents interact with the coagulation system, they cause disseminated intravascular coagulation which may lead to hypoperfusion and hypoxia. Simultaneous phagocytic activity of the neutrophils or the macrophages will eventually lead to organ failure and death [32]. The systemic inflammatory response system (SIRS) releases a pro-inflammatory response, which is another name for this kind of response to inflammation. SIRS releases a particular kind of cytokine that damages endothelium and leads to blood vessel leakage [33]. Respiratory infections are the most common infections that cause sepsis, however, other common infections include genitourinary and abdominal infections [34]. There are certain factors which raise the likelihood of sepsis depending on the site of infection, clinical interventions, genetics, patients age and baseline health [35]. One of the major causes of death in newborn babies’ ward is due to Neonatal sepsis, worldwide health care centre. About 30 million cases of sepsis are reported annually, which is about 300 cases among 100000 people [36]. The number of sepsis cases and the mortality rate in the ICU varies between countries in Europe [37]. Among the Swedish population the overall awareness of sepsis is low, only 21% knew what sepsis was in a study that surveyed the overall awareness of sepsis in Sweden [38]. Indian scenario: According to ICMR, 19% of neonatal deaths are caused by neonatal sepsis. There have been many versions in the past of what sepsis actually is which complicated the initial development of diagnostic methods for the disease. Today, sepsis patients are diagnosed by clinical presentation and fulfilment of at least two systemic inflammatory response syndrome (SIRS) criterions [39]. The SIRS criterions include body temperature, respiratory rate, heart rate and abnormalities in leukocyte count [40]. Culture of blood is the diagnostic important procedure for sepsis. However, the technique is an old technique which still has not been replaced. Although it is a useful technique sometimes cannot identify organisms growing in medium. In fact, only 30% -60% of patients suffering from sepsis or septic shock show a positive blood culture result [41]. The technique is also time consuming as it requires culturing overnight and idle time for generation results. The extensive time required for the diagnosis and delayed onset of treatment for patients puts the successful patient recovery at risk [42].  Blood culturing's limited clinical sensitivity makes it very difficult to diagnose patients receiving antibiotic therapy since it frequently produces false positive results [43]. In comparison to blood culturing, the molecular approach polymerase chain reaction (PCR) has a better clinical sensitivity and is more likely to produce positive results in patients who have already received antibiotic medication [44]. PCR is also more time effective than blood culture. Using PCR diagnostic on its own, pathogens from a whole blood sample can be detected in as little as eight hours [45]. The DNA extraction, running of the PCR and the identification of bacterial species by sequencing has been included in these eight hours. Sanger's sequencing is a commonly used method for the identification of bacterial species [46]. New methods using 16s rRNA PCR could increase the number of confirmed sepsis cases [47]. Although PCR overall has higher specificity and better time efficiency, many things seem to challenge the implementation of PCR techniques in hospitals; commercial assays need better validations, PCR costs need to decrease, PCR sensitivity needs to increase and high specificity results need to be more consistent [48]. The sensitivity in previous studies has ranged between 61% and90.9% with specificity between 70% and 100% Current commercial PCR kits on the market are include sepsitest, Magicplex neonatal septicemia Real-time (RT) PCR (Seegene) test, Vyoo (SIRS Lab) with septic Fast (Roche Diagnostics). Sepsitest (Molzym) has shown a diagnostic sensitivity and specificity of 87.0% and 85.8 %. Megaplex sepsis Real-time PCR test (seegene)has no reports on the validation of analytical or performance of clinical.

 Vyoo allows selective removal of human DNA up to 90% which increases PCR sensitivity 10 fold [49].

The test has shown to be generative while contrast blood culturing only reported 14.5% results positive. Septifast (Roche Diagnostics) has shown to generate more positive results than blood culturing [50]. Compared to blood culture, the commercial test was less likely to produce false positive results. However, there aren't many studies that compare the performance of various commercial tests to one other or to blood culturing [51]. In order to determine if the pathogens found in the PCR have high analytical sensitivity sequencing so that sequence analysis is used. Sequence analysis is usually performed against a database such as BLAST(NCBI). Based on analysis of 1500bp the bacterial species percentage identities needs to be above 98%. In order to be clinically accepted, when low species identities below 95% are found it is usually due to poor sequence alignment or lack if a sequence [52].

Therapy of Antimicrobial

It is not possible to give a single remedy for neonatal sepsis due to the antibiotic regimen. Employing antibiotics depends on various factors. Hence it is not possible to give a universal formula. However, use of antibiotics depends on blood culture of +ve & meningitis.

Antibiotics of Prophylactic

Prophylactic antibiotics cannot be used in the coming situations. Neonates on IV fluids. After exchange. An exchange transfusion done under hygienic of good atmosphere cannot increase the risk of neonatal sepsis and hence does not merit antibiotics of prophylactic nature. During the period of ventilation, the neonates should be treated with prophylactic amikacin. Therapy of empirical antibiotic can be used according to the sensitivity pattern of antibiotics; it can be modified according to the reports of sensitivity. The freedom of choosing empirical antibiotics depends on the probable origin of infections, where opposing strains are not possible, A product of gentamicin and penicillin is the best choice [53].

For hospital infections, Where pathogens are resistant, give the infant, combination ampicillin with gentamicin or amikacin. In nursery infections, Choose a blended 3rd -generation amikacin with cephalosporin. This method is more suitable. Cephalosporins have good penetration of CSF and are considered to be good antimicrobial activity against organisms of gramnegative. Nowadays, recent reports tell at-least 60 to 70% of negative gram organisms are resistant. Apart from that regular use of antibiotics increase the risk of infections with extended-spectrum beta- lactamase (ESBL) positive organisms. Hence it is always advisable to use antibiotics like vancomycin, piperacillin-tazobactam in units of high strains of resistant [54]. For Pseudomonas sepsis, use a combination of piperacillin-tazobactam with amikacin. Staph aureus of penicillin-resistant must be treated with cloxacillin and metallic. For therapy against Staphylococcus use aminoglycoside. MRSA must be employed with a blend of vancomycin along with amikacin. Ciprofloxacin does not have good penetration against CSF, but it has excellent activity against organisms of gram (-) ve. For enterococcus sepsis, a blend of ampicillin & gentamicin is good at the beginning of therapy. Usually, the chart for antibiotics are given in the guidelines. Aztreonam is good for against organisms of gram-negative. Meropenem is good in attacking most bacterial pathogens, except MRSA. Imipenem is not used in infants, because it increases the occurrence of seizures. Practical use of these antibiotics must be evaded. It should be reserved for complicated situations [55]. The mortality rate from sepsis was reduced by 50% with adjunctive therapy and ET. When used as an adjuvant, intravenous immunoglobulin (IVIG) is ineffective in septic newborns. Research on the granulocyte-macrophage colony stimulating factor (GM-CSF) therapeutic approach is also ongoing [56].

METHODS:

A prospective observational study that was carried out over several months in the pediatric and newborn intensive care units of a tertiary care hospital. Patients with a sepsis diagnosis aged 0–12 months were included. Among the pharmacist-led interventions were:

• Antimicrobial stewardship programs
• Education on sepsis management and antibiotic use
• Medication therapy optimization
• Collaborative rounds with healthcare teams.

RESULTS AND DISCUSSION:

Neonatal sepsis has an incidence rate of 12.6 per 1000 live births. The most prevalent pathogens are Klebsiella pneumoniae (20.5%), Staphylococcus aureus (23.4%), and E. coli (32.1%).

The following results of pharmacist-led interventions were attained: 40% less antibiotic misuse; 30% reduced hospital hospitalizations; 25% lower death rates; and improved patterns of antibiotic susceptibility.

CONCLUSION:

In neonatal and infant populations, pharmacist-led interventions significantly improve antibiotic therapy, sepsis care, and resistance avoidance. To improve patient outcomes and reduce the burden of sepsis, doctors, pharmacists, and other medical professionals need to work collaboratively.

REFERENCES

1. Bang AT, Bang RA, Bactule SB, Reddy HM, Deshmukh MD. Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India. Lancet 1999;354:1955-61
2. Stoll BJ. The global impact of neonatal infection.ClinPerinatol 1997;24:1-21
3. Singh M, Narang A, Bhakoo ON. Predictive perinatal score in the diagnosis of neonatal sepsis.J Trop Pediatr. 1994 Dec;40(6):365-8
4. Takkar VP, Bhakoo ON, Narang A. Scoring system for the prediction of early neonatal infections. Indian Pediatr. 1974;11:597-600
5. Baltimore RS. Neonatal nosocomial infections.SeminPerinatol 1998;22:25-32
6. Wolach B. Neonatal sepsis: pathogenesis and supportive therapy. Semin Perinatol1997;21:28-38
7. Gerdes JS, Polin R.Early diagnosis and treatment of neonatal sepsis. Indian J Pediatr 1998;65:63-78.
8. Polinski C. The value of white blood cell count and differential in the prediction of neonatal sepsis. Neonatal Netw 1996;15:13-23.
9. Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review. Pediatr Infect Dis J 1995;14:362-6 .120
10. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease.I.Refernce values for neutrophilic cells. J Pediatr 1979;95:89-98 .
11. Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R. Revised reference ranges for circulating neutrophils in verylow-birth-weight neonates. Pediatrics 1994;94:76-82.
12. Sarff LD, Platt LH, McCracken GH Jr. Cerebrospinal fluid evaluation in neonates: Comparison of high-risk neonates with and without meningitis. J Pediatr 1976;88:473-7 .
13. Upadhyay A, Aggarwal R, Kapil A, Singh S, Paul VK, Deorari AK. Profile of neonatal sepsis in a tertiary care neonatal unit from India: A retrospective study. Journal of Neonatology 2006;20:50-57.
14. Deorari Ashok K. For the Investigators of the National Neonatal Perinatal Database (NNPD).Changing pattern of bacteriologic profile in Neonatal Sepsis among intramural babies. Journal of Neonatology2006; 20:8-15.
15. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital acquired neonatal infections in developing countries. Lancet 2005;365:1175-88.
16. Kenzel S, Henneke L. The innate immune system and its relevance to neonatal sepsis.CurrOpin Infect Dis. 2006; 19(3):264-70.
17. Jain NK, Jain VM, Maheswaris. Clinical profile of neonatal sepsis, Kathmandu UnivMedJ. 2003; 1:117-20.
18. Bang AT, Bang RA, Baitule SB, et al. Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India.Lancet.1999 Dec;4;354(9194):1955-61.121
19. Baltimore R . Neonatal Sepsis Epidemiology and Management. Peadiatric Drug. 2003;5:723.
20. Report of the National Neonatal Perinatal Database. Report 2002- 2003NNPD Network2005.
21. Jeffery S, GerdesRichard P. Early diagnosis, and treatment of neonatal sepsis.Indian J Pediatr.1998;65:63-71.
22. Stoll BJ, Behrman, Kleigman RM, Jenson HB. Infections of the neonatal infant. Nelson textbook of pediatrics, 17th ed. Philadephia Sumders. 2004;623-40.
23. Rohsiswatmo R, KontrovorsiHegar B, Trihono PP, Ifran EB. Diagnosis sepsis neonatorum.updata in neonatal Infection.FKUI-RSLM;2005;32- 43.
24. Shan Gs, Budhathoki S, Das BK, Mandal. Risk factors in early neonatal sepsis. Kathmandu University Medical Journal. 2006; 4(14):187-191.
25. Ahmed AS, Chowdhury MA, HoqueM, Darmstadt GL. The clinical and bacteriological profile of neonatal septicemia in a tertiary level pediatric hospital in Bangladesh.Indian pediatr.2002;39:1034-39.
26. Mathur B.Neonatal sepsis.Indianpediatr.1996;33:633-74.
27. Aftab R, Iqbal.Bacteriological agents of neonatal sepsis in NICU at Nishtar hospital, Multan.Jcoll Physicians Surg Pak.2006:16(3):216-9.
28. Zaidi AKM, Huskinwc, Thaver D, Bhutta ZA, Abbass, Goldman.Hospital-acquired neonatal infections in developing countries lancet.2005;365(9465):1175-88.122
29. Orbes BA. Sahm DF, Weisfeld. Pseudomonas, Burkholderia, and similar organisms. In: probe. Bailey and Scott’s Diagnostic microbiology.11thed. St.Louis: Mosby Inc:2002.P.448-61.
30. Liesenfeld O, Lehman L. Molecular Diagnosis of Sepsis New Aspects and Recent Developments. European Journal of Microbiology and Immunology.2014;4(1)1-25.
31. Signore A. About inflammation and infection. EJNMMI Research. 2013; 3(1):8.
32. Danikas D.D, Karakantza M, Theodorou, Sakellaropoulos GC, Gogos A. Prognostic value of the agnostic activity of neutrophils and monocytes in sepsis. correlation to CD64andCD14 antigen experimental Immunology.2008; 154(1):87-97.
33. VanAmersfoort ES.,VanBerkel TJC.,KuiperJ. Receptors Mediators, and Mechanisms Involved Bacterial Sepsis and Septic Shock.Clinical Microbiology Reviews.2003;16(3):379-414.
34. Dellinger RP. Inflammation and Coagulations for the Septic Patient. Clinical Infectious Diseases. 2003; 36(10): 1259–1265.
35. Martin GS. Sepsis, Severe Sepsis, and Septic Shock: changes in incidence, Pathogens, and outcomes. Expert Review of Anti-Infective Therapy.2012;10(6):701- 6.
36. Liesenfeld O, Lehman L, Molecular Diagnosis of Sepsis New Aspects and Recent Developments. European Journal of Microbiology and Immunology.2014;4(1):1-25.
37. Mellhammar L., Christensen B., Linder, A. Public awareness of sepsis Is Low in Sweden.Open Forum Infectious Diseases. 2015;2(4):1-5.123
38. Vincent J-L, Sakr Y, Sprung CL., Ranieri VM, et al. Sepsis in European intensive care units: Results of the SOAP study. Critical care medicine. 2006Feb;34(2):344-53.
39. Tallur SS,Kasturi AV,Shobha D,Krishna BVS.Clinico-bacteriological study of neonatal septicaemia in Hubli.Indian Journal paediatrics. 2000;67(3):169-174.
40. Liesenfeld O, Lehman L, Molecular Diagnosis of Sepsis New Aspects and Recent Developments. European Journal of Microbiology and Immunology. 2014;4(1)1-25.
41. Ratzinger F, Schuardt M, Eichbichler K, et al. utility of Sepsis Biomarkers and the Infection probability Score to Discriminate Sepsis and Systemic Inflammatory Response Syndrome in Standard Care Patients. PLoSoNE. 2013;8(12):e82946.
42. Morgenthaler NG and Kostrzewa. Rapid Identification of pathogens in Blood Culture of Patients with Sepsis: Review and meta-analysis of the Performance of the Sepsityper kit. International Journal of Microbiology. 2015;1-10.
43. Rogina P, Skvarc M, Stubljar D, Kofol R, Karachi. Diagnostic Utility of Broad Range bacterial 16srRNA Gene PCR with Degradation of Human and Free Bacterial DNA in Blood Stream infection is More Sensitive Than an in-house Developed PCR without Degradation of Human and Free Bacterial DNA.Mediators of Inflammation.2014;1-7.
44. Saah AJ and Hoover DR. Sensitivity and Specificity Reconsidered: The Meaning of
45. These Terms in Analytical and Diagnostic Setting. Annals of Internal Medicine. 1997: 126(1):91-94.124
46. Schreiber .J., Nierhaus A., Braune SA., de Heere, Kluge S. Comparison of three different commercial PCR assays for the detection of Pathogens in Critically ill Sepsis Patients. National Center for Biotecnology Information.2013 May;108(4):311-8.
47. Laffler TG, Cummins LL, Mcclainbc M, Quinnbc. Dorota MA,et al. Enhanced Diagnostic yields of Bacteremia and Candidemia in Blood Specimens by PCR Electrospray Ionization Mass Spectrometry. Journal of Clinical Microbiology.2013;51(11)3535-3541.
48. Tillmer AO, DellAmico B, Welander J, GunillaHolmlund GA. Universal Method for Species Identification of Mammals utilizing Next Generation Sequencing for the Analysis of DNA Mixtures. 2013;Dec 16;8(12):e83761.
49. Jordana-Liuch E, Gimenez M, Sampath R, EckerDJ, Dolores Quesada M, et al. Diagnosis of Blood Stream Infections with PCR Followed by Mass Spectrometry.2013;Apr 23;8(4):e62108.
50. Jordana-LE., Gimenez M., SampathR.,EckerDJ, et al. Rapid Diagnosis of Blood Stream Infections with PCR Followed by Mass spectrometry. 2013;8(4):e62108.
51. Schreiber J, Nierhaus A, Braune SA, de Heere, Kluge S. comparison of three different commercial PCR assays for the detection of Pathogens in Critically ill Sepsis Patients. National Center for Biotecnology Information.2013; 108(4):311-8.
52. Liesenfeld O, Lehman L, Molecular Diagnosis of Sepsis New Aspects and Recent Developments. European Journal of Microbiology and Immunology 2014;4(1):1-25.125
53. Liesenfeld O, Lehman L, Molecular Diagnosis of Sepsis New Aspects and Recent Developments. European Journal of Microbiology and Immunology.2014;4(1):1–25.
54. Barghouthi S.A.A Universal Method for the Identification of Bacteria Based on General PCR primers.Indian Journal of Microbiology 2011; 51(4):430–444.
55. Sadana S, Mathur NB, Thakur A. Exchange transfusion in septic neonates with sclerema: effect on immunoglobulin and complement levels. Indian Pediatr 1997;34:20-5 .
56. Jenson HB, Pollock HB. The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis.SeminPerinatol 1998;22:50-63.